Skip to content

Clinical trials

Phase 2 Myeloproliferative Disorders trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Status: Unknown status Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20131
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center1
Herbert Irving Comprehensive Cancer Center1
Medical College of Wisconsin1
University Of Perugia1
University of Bologna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders5
Myelodysplastic Syndromes4
Lymphoma3
Multiple Myeloma3
Myelodysplastic-Myeloproliferative Diseases3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Blast Crisis2
Burkitt Lymphoma2
Dendritic Cell Sarcoma, Interdigitating2
Leukemia2

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.